P&G Hits Teva With New Actonel Suit
Procter & Gamble Co. has asserted three patents against Teva Pharmaceuticals USA Inc. in a new suit over the osteoporosis drug Actonel, a development that comes as P&G and Teva await...To view the full article, register now.
Already a subscriber? Click here to view full article